|
Post by kimi on Aug 8, 2017 8:04:12 GMT -5
So we're very optimistic as we go forward; there's nothing I've heard in the market research that tells me we're not going to make this drug phenomenally successful.
|
|
|
Post by promann on Aug 8, 2017 8:11:41 GMT -5
So we're very optimistic as we go forward; there's nothing I've heard in the market research that tells me we're not going to make this drug phenomenally successful. Exactly!! Afrezza is the best treatment for Diabeties in so many ways. Not getting injected and being able to inhale it is just another perk and not the only advantages as most people think.
|
|
|
Post by #NoMoreNeedles on Aug 8, 2017 8:11:46 GMT -5
Cash flow? Issue more shares? Reverse split? Investors? Not enough was shared yesterday!
|
|
|
Post by peppy on Aug 8, 2017 8:13:15 GMT -5
the thing Afrezza has going for it, is it is excellent insulin. how do I know?
I use my eyeballs.
VS subq insulin given by insulin pump.
|
|
|
Post by roseylv on Aug 8, 2017 12:02:51 GMT -5
So we're very optimistic as we go forward; there's nothing I've heard in the market research that tells me we're not going to make this drug phenomenally successful. kimi, i understand the post but come on...What else do you expect a CEO of publicly traded company to say? That line was taken from a CEO 101 class. Now don't get me wrong, we all have eggs in Mike C's basket so I am sure as shit routing for him and the entire MNKD team to succeed.
|
|
|
Post by babaoriley on Aug 8, 2017 12:17:42 GMT -5
Cash flow? Issue more shares? Reverse split? Investors? Not enough was shared yesterday! Not everything need be shared. Think back to movies before 1968 or so, you'd see a long kiss, and the screen would fade into the next scene (and not always of a train going through a tunnel, or, perhaps a view of the Washington Monument). No one doubted what was going to happen, just because they didn't show it.
|
|
|
Post by sportsrancho on Aug 8, 2017 12:36:32 GMT -5
So we're very optimistic as we go forward; there's nothing I've heard in the market research that tells me we're not going to make this drug phenomenally successful. I agree kimi. If wasn't like Mike got stuck with this company. He did the homework before he came over. It was his opinion that he could turn things around. He saw massive potential.
|
|
|
Post by radgray68 on Aug 8, 2017 13:25:34 GMT -5
Great statement. I liked the enthusiasm and confidence. It didn't hurt that they had the slides to back up the hype. I also heard the terms year-over-year growth and quarter-over-quarter growth. As I've been saying for years now, GROWTH is what Wallstreet pays attention to. Growth is the blood in the water that the sharks can't pass up.
We have a real "Big Pharma" management team in place now and they speak Wallstreeteese. I'm moving some cash over to my trading account to buy some actual shares to go with my options. If we're not at a bottom now, then one more short attack would be close enough for my comfort. They aren't going to do a massive dilution like the shorts would like here. If scaling up sales is as certain as management believes, we're done being a giant question mark. Yeay!
|
|
|
Post by sportsrancho on Aug 8, 2017 13:30:26 GMT -5
👍👍👍
|
|
|
Post by uvula on Aug 8, 2017 13:44:57 GMT -5
Afrezza successful - probably will be. Mnkd successful - that is an entirely different matter.
|
|
|
Post by dreamboatcruise on Aug 8, 2017 14:13:06 GMT -5
Cash flow? Issue more shares? Reverse split? Investors? Not enough was shared yesterday! Statement was purely about the drug being successful. I can get on board with that fully. What is in store for current shareholders? There, some things can still be seen as dark clouds. The revenue growth projections are encouraging though. Sales have a way of chasing dark clouds away. I'm more hopeful about stock after the conference call... whereas I've always felt Afrezza would be phenomenally successful.
|
|
|
Post by me on Aug 8, 2017 14:37:20 GMT -5
Afrezza successful - probably will be. Mnkd successful - that is an entirely different matter. While this comment is painful to longs, this is the reality. We longs need to always be careful not to conflate Afrezza's success with current MNKD shareholder success.
|
|
|
Post by lennymnkd on Aug 8, 2017 14:56:50 GMT -5
Or AFREZZA success / or "TECHNOSPHERE " success ! Two sperate successes
|
|
|
Post by lennymnkd on Aug 8, 2017 19:59:21 GMT -5
In regards to their intention to bring TREPROSTINIL TO MARKET ... did they just see a good opportunity and were fimilar with it : or do you think they are working with and partnering with someone who approached them .. I'm suspecting a knowledgeable sale team is needed to bring this to market : royalties are always in the cards I guess .
|
|
|
Post by dreamboatcruise on Aug 8, 2017 20:21:46 GMT -5
In regards to their intention to bring TREPROSTINIL TO MARKET ... did they just see a good opportunity and were fimilar with it : or do you think they are working with and partnering with someone who approached them .. I'm suspecting a knowledgeable sale team is needed to bring this to market : royalties are always in the cards I guess . They along with the advisory firm hired are likely talking to potential partner(s). I would assume that they would announce any material partnership as they should if it were to already be in place. MNKD has previously said they were not considering taking any of the other API to market on their own.
|
|